Mode of Action of Peroxisome Proliferators as Hypolipidemic Drugs.
Open Access
- 1 June 1995
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 270 (22), 13470-13475
- https://doi.org/10.1074/jbc.270.22.13470
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Transcriptional activation by amphipathic carboxylic peroxisomal proliferators is induced by the free acid rather than the acyl‐CoA derivativeEuropean Journal of Biochemistry, 1994
- Specific repression of transthyretin gene expression in rat liver by a peroxisome proliferator clofibrateBiochemical and Biophysical Research Communications, 1992
- Tissue selective modulation of redox and phosphate potentials by beta,beta'-methyl-substituted hexadecanedioic acidEndocrinology, 1992
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990
- Synthesis and hypolipidemic and antidiabetogenic activities of .beta.,.beta.,.beta.',.beta.'-tetrasubstituted, long-chain dioic acidsJournal of Medicinal Chemistry, 1989
- Effects of fibrates on serum lipids and atherosclerosisPharmacology & Therapeutics, 1988
- Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.Journal of Clinical Investigation, 1986
- Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid estersAtherosclerosis, 1980
- Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.Journal of Clinical Investigation, 1980
- Increase in Lipoprotein Lipase during Clofibrate Treatment of Hypertriglyceridemia in Patients on HemodialysisNew England Journal of Medicine, 1979